CN105116076A - Method for detecting cefodizime sodium related substances - Google Patents
Method for detecting cefodizime sodium related substances Download PDFInfo
- Publication number
- CN105116076A CN105116076A CN201510624851.8A CN201510624851A CN105116076A CN 105116076 A CN105116076 A CN 105116076A CN 201510624851 A CN201510624851 A CN 201510624851A CN 105116076 A CN105116076 A CN 105116076A
- Authority
- CN
- China
- Prior art keywords
- cefodizime sodium
- cefodizime
- mobile phase
- solution
- related substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The invention relates to a method for detecting cefodizime sodium related substances. Ammonium dibasic phosphate and acetonitrile are served as mobile phases to perform gradient elution; and cefodizime can be effectively separated from the related substances.
Description
Technical field
The present invention relates to a kind of detection method of Cefodizime Sodium related substance.
Background technology
Cefodizime Sodium (cefodizime) is as third-generation cephalosporin, in the world first by German HoechstRoussel Developed, go through in Japan's listing (trade name: Neucef) in nineteen ninety, within 1994, go through in importer, domestic and international clinical practice has the history of nearly 20 years.
The known at present impurity of this product is: 2-sulfydryl-4-methyl-5-thiazole acetic acid (related substance I) and Δ-2 Cefodizime (related substance II).
The existing liquid phase testing conditions of Cefodizime Sodium is mixed into mobile phase with 920:80, isocratic elution with phosphate buffer (get potassium dihydrogen phosphate 0.87g and ADSP 0.22g, be dissolved in water and be diluted to 1000ml, shaking up) and acetonitrile.Though the method can realize effectively being separated of Cefodizime and related substance, be difficult to tackle the separation of complicated ingredient under the accelerated test conditions such as acid, alkali, high temperature.
Summary of the invention
The present invention relates to a kind of new method that Cefodizime Sodium related substance is detected:
Need testing solution: get cefodizime sodium for injection appropriate, dissolves with water for injection and is quantitatively diluted to the solution of 0.5mg/ml;
Mobile phase A: 5mmol/L ammonium dibasic phosphate solution;
Mobile phase B: acetonitrile;
Chromatographic column: 200mm × 4.6mm, 5 μm;
Filler: C18 alkyl silane bonded silica gel;
Column temperature: 25 DEG C;
Determined wavelength: 262nm;
Flow velocity: 1.0mL/min;
Condition of gradient elution:
Time/min | Mobile phase A (%) | Mobile phase B (%) |
0 | 95 | 5 |
15 | 80 | 20 |
20 | 80 | 20 |
25 | 95 | 5 |
30 | 95 | 5 |
Get above-mentioned need testing solution 20 μ l, inject high performance liquid chromatograph, record chromatogram.
Adopt detection method of the present invention can realize effectively being separated of Cefodizime Sodium and related substance I, related substance II and trans Cefodizime, degree of separation is good, and has good reappearance.
Accompanying drawing explanation
Fig. 1 adopts detection method of the present invention Cefodizime Sodium to be detected to the liquid chromatogram obtained.
Embodiment
Need testing solution: get cefodizime sodium for injection appropriate, dissolves with water for injection and is quantitatively diluted to the solution of 0.5mg/ml;
Mobile phase A: 5mmol/L ammonium dibasic phosphate solution;
Mobile phase B: acetonitrile;
Chromatographic column: 200mm × 4.6mm, 5 μm;
Filler: C18 alkyl silane bonded silica gel;
Column temperature: 25 DEG C;
Determined wavelength: 262nm;
Flow velocity: 1.0mL/min;
Condition of gradient elution:
Time/min | Mobile phase A (%) | Mobile phase B (%) |
0 | 95 | 5 |
15 | 80 | 20 |
20 | 80 | 20 |
25 | 95 | 5 |
30 | 95 | 5 |
Get above-mentioned need testing solution 20 μ l, inject high performance liquid chromatograph, record chromatogram.
Differentiated by the ownership of internal standard method to impurity peaks, result is as follows:
Synergy | RT | Content (%) |
2-sulfydryl-4-methyl-5-thiazole acetic acid | 3.280 | 0.11 |
Δ-2 Cefodizime | 6.477 | 0.03 |
Cefodizime | 7.267 | 99.6 |
Trans Cefodizime | 10.460 | 0.06 |
Claims (2)
1. a detection method for Cefodizime Sodium related substance, is characterized in that:
Need testing solution: get cefodizime sodium for injection powder appropriate, dissolves with water for injection and is quantitatively diluted to the solution of 0.5mg/ml;
Mobile phase A: 5mmol/L ammonium dibasic phosphate solution;
Mobile phase B: acetonitrile;
Chromatographic column: 200mm × 4.6mm, 5 μm;
Filler: C18 alkyl silane bonded silica gel;
Column temperature: 25 DEG C;
Determined wavelength: 262nm;
Flow velocity: 1.0mL/min;
Condition of gradient elution:
Get above-mentioned need testing solution 20 μ l, inject high performance liquid chromatograph, record chromatogram.
2. the detection method of Cefodizime Sodium according to claim 1, is characterized in that: differentiated by the ownership of internal standard method to impurity peaks, result is as follows:
。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510624851.8A CN105116076B (en) | 2015-09-28 | 2015-09-28 | A kind of detection method of Cefodizime Sodium about material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510624851.8A CN105116076B (en) | 2015-09-28 | 2015-09-28 | A kind of detection method of Cefodizime Sodium about material |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105116076A true CN105116076A (en) | 2015-12-02 |
CN105116076B CN105116076B (en) | 2017-06-30 |
Family
ID=54664116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510624851.8A Active CN105116076B (en) | 2015-09-28 | 2015-09-28 | A kind of detection method of Cefodizime Sodium about material |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105116076B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109900812A (en) * | 2017-12-07 | 2019-06-18 | 北京济美堂医药研究有限公司 | Cefixime and its detection method in relation to substance |
CN112067709A (en) * | 2020-07-03 | 2020-12-11 | 海口市制药厂有限公司 | Method for determining cefodizime sodium related substance for injection and application |
WO2022247200A1 (en) * | 2021-05-28 | 2022-12-01 | 海南海灵化学制药有限公司 | Method for detecting impurities in latamoxef sodium |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014107536A1 (en) * | 2013-01-04 | 2014-07-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN104165949A (en) * | 2014-08-29 | 2014-11-26 | 四川制药制剂有限公司 | Inspection method for cefodizime sodium polymer for injection |
CN104215714A (en) * | 2014-09-21 | 2014-12-17 | 四川制药制剂有限公司 | Determination method of related substance of cefodizime sodium for injection |
-
2015
- 2015-09-28 CN CN201510624851.8A patent/CN105116076B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014107536A1 (en) * | 2013-01-04 | 2014-07-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN104165949A (en) * | 2014-08-29 | 2014-11-26 | 四川制药制剂有限公司 | Inspection method for cefodizime sodium polymer for injection |
CN104215714A (en) * | 2014-09-21 | 2014-12-17 | 四川制药制剂有限公司 | Determination method of related substance of cefodizime sodium for injection |
Non-Patent Citations (5)
Title |
---|
TERUYOSHI MARUNAKA 等: "Acidic degradation of cefodizime(THR-221) and structural elucidation of the products.I", 《CHEM.PHARM.BULL.》 * |
刘雁鸣 等: "HPLC-DAD法对注射用头孢地嗪钠杂质谱的一致性分析研究", 《中国药品标准》 * |
姜晓峰 等: "头孢地嗪钠含量和有关物测定方法研究", 《食品与药品》 * |
钟莹 等: "HPLC梯度洗脱法测定注射用头孢地嗪钠的有关物质", 《中国抗生素杂志》 * |
黄秀芬 等: "注射用头孢地嗪钠中特定杂质巯噻唑酸的含量测定", 《今日药学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109900812A (en) * | 2017-12-07 | 2019-06-18 | 北京济美堂医药研究有限公司 | Cefixime and its detection method in relation to substance |
CN112067709A (en) * | 2020-07-03 | 2020-12-11 | 海口市制药厂有限公司 | Method for determining cefodizime sodium related substance for injection and application |
WO2022247200A1 (en) * | 2021-05-28 | 2022-12-01 | 海南海灵化学制药有限公司 | Method for detecting impurities in latamoxef sodium |
Also Published As
Publication number | Publication date |
---|---|
CN105116076B (en) | 2017-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Blankenburg et al. | Improving proteome coverage for small sample amounts: an advanced method for proteomics approaches with low bacterial cell numbers | |
CN104237421B (en) | A kind of relevant substance detecting method of succinum love song Ge Lieting and preparation thereof | |
CN105651871A (en) | Determination method of rivaroxaban and related substances | |
Zhang et al. | Determination of eight quinolones in milk using immunoaffinity microextraction in a packed syringe and liquid chromatography with fluorescence detection | |
CN105116076A (en) | Method for detecting cefodizime sodium related substances | |
Fan et al. | Extraction and purification of capsaicin from capsicum oleoresin using an aqueous two-phase system combined with chromatography | |
CN107238672A (en) | The content assaying method of impurity in a kind of isoniazid or its pharmaceutical composition | |
Dong et al. | Isolation of immunoglobulin G from bovine milk whey by poly (hydroxyethyl methacrylate)‐based anion‐exchange cryogel | |
Correia et al. | Recovery of biological active catechol‐O‐methyltransferase isoforms from Q‐sepharose | |
CN105301159A (en) | High performance liquid chromatography analysis method of sirolimus | |
CN106770849B (en) | A kind of detection method measuring doxercalciferol and its impurities | |
CN105467021A (en) | Method for separation determination of related substances in bulk drugs and preparations of paricalcitol through HPLC method | |
CN101929988B (en) | Method for detecting febuxostat-associated matters by using high performance liquid chromatography | |
Wang et al. | An enzyme-assisted and nitrogen-blowing salt-induced solidified floating organic droplet microextraction for determination of clenbuterol and ractopamine in swine feed via capillary electrophoresis | |
CN102384946B (en) | By the method for high efficiency liquid chromatography for separating and determining Entecavir and diastereo-isomerism thereof | |
CN104784972A (en) | Preparation method and application of hesperidin immunoaffinity column | |
CN104535688B (en) | A kind of assay method of Sustained Release Ambroxol Hydrochloride Capsules release | |
CN104122361B (en) | Utilize the method for the beautiful more soft capsule of efficient liquid phase chromatographic analysis ammonia | |
CN107589212A (en) | A kind of detection method of amoxil capsule about material | |
CN104764840A (en) | Method for separating and detection palonosetron hydrochloride and impurity | |
CN102901783A (en) | Content determination method for pranoprofen eye drops | |
CN106018573A (en) | Method for detecting purity of tipiracil hydrochloride in TAS-102 | |
CN103012435A (en) | Cefodizime sodium preparation method | |
CN110907582A (en) | Method for detecting celecoxib-related impurities and application thereof | |
CN101464432B (en) | Method for measuring Cidofovir related substance by high efficiency liquid chromatography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |